Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,687,213
-$324,045 QoQ
Shares Held
70,067
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,024
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLAGSHIP HARBOR ADVISORS, LLC holds $34,099,548 across 12 Drug Manufacturers - General names. PFE ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,533 | $7,754,466 | |
| 2 | ABBV |
AbbVie Inc.
|
28,893 | $7,270,634 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,083 | $6,435,665 | |
| 4 | LLY |
ELI LILLY & Co
|
4,913 | $5,892,800 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
29,492 | $1,699,329 | |
| 6 | PFE |
Pfizer Inc
This page
|
70,067 | $1,687,213 | |
| 7 | AMGN |
Amgen Inc
|
2,672 | $967,584 | |
| 8 | AZN |
Astrazeneca PLC
|
2,895 | $548,949 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,687,213 | 70,067 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,011,258 | 71,626 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,848,526 | 74,238 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,970,776 | 77,346 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,795,408 | 74,068 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,682,576 | 66,400 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,719,541 | 64,815 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,846,806 | 63,815 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,812,040 | 64,762 | Shares | Sole | 2025-12-02 | |
| 2024-03-31 | $1,849,898 | 66,663 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,634,523 | 56,774 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,702,284 | 51,320 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,886,305 | 51,426 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $2,527,152 | 61,940 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,159,099 | 61,653 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,380,544 | 54,400 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,745,287 | 52,361 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $2,710,366 | 52,354 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $3,077,804 | 52,122 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $2,145,252 | 49,878 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,953,222 | 49,878 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,884,503 | 52,015 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,001,875 | 54,384 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,976,256 | 53,849 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,881,625 | 57,542 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,379,070 | 42,251 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||